Invited Speakers

1. Keith Jensen, Ph.D. (MIT, USA)

“Continuous Manufacturing of Tablets via Hot-Melt Extrusion and Coupled Injection Molding”

Dr. Keith Jensen has been consulting for companies in the US and China on continuous manufacturing and pharmaceutical formulation and process development. Before consulting, Keith was the Associate Director and Principle Investigator of the Novartis-MIT Center of Continuous Manufacturing at the Massachusetts Institute of Technology (Department of Chemical Engineering, Cambridge, Massachusetts, USA) from 2014 to 2017. The Center was a 10-year research program on developing end-to-end continuous manufacturing of pharmaceuticals. He led a translation team of research scientists, engineers, and post-docs. They developed new technologies and processes for continuous manufacturing of pharmaceuticals from proof of principle, scale-up, and translation (transfer and implementation) into pharmaceutical product production.

Keith’s background includes a Bachelor of Science (Hons) in Chemistry, Ph.D. in Pharmaceutics and Pharmaceutical Chemistry and a postdoctoral fellowship at the University of Utah before entering the pharmaceutical industry. He joined LTS Lohmann where he led a formulation group developing oral thin film dosage forms. The main emphasis of research centered on solving difficult drug delivery problems via buccal delivery and solving poor solubility challenges. After +10 years at LTS he joined the Center at MIT. For the last two years, Dr. Jensen has been a member of the USP Expert Panel on Continuous Manufacturing of Pharmaceuticals.

2. Niklas Sandler, Ph.D.(Abo Academic University, Finland)

“Recent advances in using printing technologies in manufacturing drug-delivery systems”

Niklas Sandler received his M.Sc. (Pharm.) in 1998 from University of Helsinki, Finland. He got his Ph.D. in pharmaceutical technology from the University of Helsinki 2003. He was lecturer at the Pharmaceutical Technology Division, Helsinki between 2003- 2005 and in 2005-2006 he was a postdoctoral researcher at the University of Otago, New Zealand, focusing on research on solid- state characterization of drugs. He became an adjunct professor in Pharmaceutical Technology at the University of Helsinki in 2007. Between 2006 and 2008 he had a senior researcher position at AstraZeneca, Pharmaceutical and Analytical R&D in the UK. From September 2008 until July 2009 was a temporary professor in Industrial Pharmacy at the University of Helsinki. Since August 2009 he has been full professor in Pharmaceutics at Åbo Akademi University (ÅAU), Turku, Finland and heads the research group in drug-delivery and pharmaceutical technology. He has pioneered in research about printable drug-delivery systems. The current aim of his research group is to increase the understanding of material behaviour in fabrication of printed drug-delivery systems and to explore various printing techniques in drug manufacture. He is the president of the Finnish Pharmaceutical Society since 2012. Vice rector responsible for research affairs and innovations of Åbo Akademi University since 2015. He has been an Executive Board Member of EUFEPS from 2013 onwards.

He has published about 100 papers in major international peer-reviewed journals since 2000, with ca. 1600 citations (approximately 1300 since 2012), h -index of 24. The publications have been published in wide range of scientific journals. In addition, 3 granted patents and several patent applications. He has been managing projects as Principal investigator in various research and commercialization projects funded by the Academy of Finland, Business Finland (National Innovation Agency), and the pharmaceutical industry.

3. Kenji Sugibayashi, Ph.D. (Josai International University, Japan)

Kenji Sugibayashi, Ph.D. is the president of Josai International University, a trustee of Josai University Educational Corporation and a professor at the Faculty of Pharmacy and Pharmaceutical Sciences, Josai University. He received B.S. and M.S. from the University of Toyama in 1974 and 1976, respectively. He started to work at Josai University from 1976. He got a Ph.D. from Gifu Pharmaceutical University in 1981. He was a post-doctoral fellow at the University of Michigan and University of Utah in 1982-3, working for Dr. William I. Higuchi. Dr. Sugibayashi’s major is pharmaceutical and cosmetic sciences. He has written more than 300 original articles, 120 reviews, 50 patents and edited several books. He has just published a book named “Skin Permeation and Disposition of Therapeutic and Cosmeceutical Compounds” from Springer. He was the president of the Academy of Pharmaceutical Science and Technology, Japan (APSTJ) during 2009-10, a vice-president at the Japanese Cosmetic Science Society (JCSS) till the last year and a board member of directors at the Japanese Society for Alternative to Animal Experiments (JSAAE). He received many scientific awards; like the Asian Federation for Pharmaceutical Sciences (AFPS) Nagai Distinguished Scientist Award 2017, the JSAAE Achievement Award 2015, the Shukri Distinguished Keynote Lecture Award at the Asia Pacific Pharmacy Education Workshop in 2014, the APSTJ Award 2013, APSTJ Best Paper Award in 2013, 2011, 2009 and 1993, JOC (Japan Oleo Chemistry) Best Editor Award in 2012, AATEX Best Paper Award in 2002, APSTJ Young Researcher Award in 1996, and many. He is now a key member in the Asia Pacific Pharmacy Education Network (AP-PEN).